Health
Platform reveals insights into cancer genomics and personalised medicine – Drug Target Review
Researchers have developed a personalised medicine platform that they say could advance genomic medicine research for cancer.
Posted: 9 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have developed a personalised medicine platform that could advance genomic medicine research for cancer.
A team of researchers has developed a personalised genomic medicine platform that they say will help to accelerate genomic medicine research and genome-informed drug discovery. The study was conducted at the Cleveland Clinic, US.
Known as My Personal Mutanome (MPM), the platform features an interactive…
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News9 hours agoLune Has Launched a Loyalty Program to Reward Your Love of World-Famous Croissants and Other Tasty Pastries